Status:
RECRUITING
Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis
Lead Sponsor:
Medical University Innsbruck
Conditions:
Rheumatic Arthritis
Interstitial Lung Disease in Patients With Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to develop a standardized, risk-adapted screening protocol for detecting pleuropulmonary manifestations in patients with rheumatoid arthritis. To assess the risk of these manif...
Detailed Description
The objective of the study is the establishment of a standardized risk-adapted screening protocol for detecting pleuropulmonary manifestations in patients with rheumatoid arthritis. To determine the r...
Eligibility Criteria
Inclusion
- Patients ≥18 years diagnosed with rheumatoid arthritis according to current ACR/EULAR criteria
- Residence in Austria
- Signed and dated consent of the patient in accordance with ICH-GCP guidelines
Exclusion
- pregnancy
- age below 18 years
- Contraindications to study-related routine examinations (e.g., inability to draw blood due to needle phobia, no CT scan possible due to claustrophobia, pregnancy, etc.)
Key Trial Info
Start Date :
November 11 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2029
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT06965322
Start Date
November 11 2024
End Date
September 30 2029
Last Update
December 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University Innsbruck
Innsbruck, Austria, Austria, 6020